99 related articles for article (PubMed ID: 1745334)
1. [Structure and function of receptors for C3 cleavage fragments].
Fischer E; Couturier C; Weiss L; Kazatchkine MD
Nephrologie; 1991; 12(4):169-78. PubMed ID: 1745334
[TBL] [Abstract][Full Text] [Related]
2. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
3. The human C3b receptor (CR1).
Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
[TBL] [Abstract][Full Text] [Related]
4. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
7. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
Lambris JD; Ross GD
J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
[TBL] [Abstract][Full Text] [Related]
8. Macrophage complement receptors and pathogen clearance.
van Lookeren Campagne M; Wiesmann C; Brown EJ
Cell Microbiol; 2007 Sep; 9(9):2095-102. PubMed ID: 17590164
[TBL] [Abstract][Full Text] [Related]
9. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
Edwards JE; Gaither TA; O'Shea JJ; Rotrosen D; Lawley TJ; Wright SA; Frank MM; Green I
J Immunol; 1986 Dec; 137(11):3577-83. PubMed ID: 2946764
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
Vik DP; Fearon DT
J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
[TBL] [Abstract][Full Text] [Related]
11. The many effects of complement C3- and C5-binding proteins in renal injury.
Puri TS; Quigg RJ
Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
[TBL] [Abstract][Full Text] [Related]
12. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
[TBL] [Abstract][Full Text] [Related]
13. The complement fragment C3d facilitates phagocytosis by monocytes.
Gaither TA; Vargas I; Inada S; Frank MM
Immunology; 1987 Nov; 62(3):405-11. PubMed ID: 3499379
[TBL] [Abstract][Full Text] [Related]
14. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
[TBL] [Abstract][Full Text] [Related]
15. [Role of the complement C3 protein in the control of the specific immune response].
Villiers CL; Villiers MB; Marche PN
Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
[TBL] [Abstract][Full Text] [Related]
16. [Cellular receptors and regulator proteins reacting with C3 activation products].
Garred P
Tidsskr Nor Laegeforen; 1991 Feb; 111(6):709-13. PubMed ID: 2008693
[TBL] [Abstract][Full Text] [Related]
17. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
18. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
19. Complement components and receptors: deficiencies and disease associations.
Bartholomew WR; Shanahan TC
Immunol Ser; 1990; 52():33-51. PubMed ID: 2091785
[TBL] [Abstract][Full Text] [Related]
20. Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3.
Fischer E; Capron M; Prin L; Kusnierz JP; Kazatchkine MD
Cell Immunol; 1986 Feb; 97(2):297-306. PubMed ID: 3742611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
